Uni-charm Indonesia PT
IDX:UCID
Uni-charm Indonesia PT
IDX:UCID
Price:
720
IDR
-0.69%
Market Cap:
3T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
UCID Alert
Uni-charm Indonesia PT
720
-5 (-0.69%)
| 52 Week Range |
715
1 030
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Uni-charm Indonesia PT
Balance Sheet
Balance Sheet Decomposition
Uni-charm Indonesia PT
Uni-charm Indonesia PT
| Current Assets | 5.8T |
| Cash & Short-Term Investments | 2.1T |
| Receivables | 2.3T |
| Other Current Assets | 1.4T |
| Non-Current Assets | 2.8T |
| PP&E | 2.2T |
| Other Non-Current Assets | 624.2B |
| Current Liabilities | 2.6T |
| Accounts Payable | 1T |
| Accrued Liabilities | 1.3T |
| Other Current Liabilities | 296.4B |
| Non-Current Liabilities | 303.8B |
| Long-Term Debt | 146.4B |
| Other Non-Current Liabilities | 157.5B |
Balance Sheet
Uni-charm Indonesia PT
Uni-charm Indonesia PT
Currency: IDR
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
862 760
|
1 110 939
|
1 140 083
|
1 986 649
|
1 428 189
|
1 499 252
|
1 372 156
|
1 852 974
|
|
| Cash |
862 760
|
1 110 939
|
1 140 083
|
1 986 649
|
1 428 189
|
1 499 252
|
1 372 156
|
1 852 974
|
|
| Short-Term Investments |
1 323
|
1 332
|
1 133
|
1 088
|
1 104
|
1 117
|
1 231
|
0
|
|
| Total Receivables |
2 004 804
|
2 037 634
|
2 115 870
|
2 885 837
|
2 527 227
|
2 325 395
|
3 014 121
|
2 447 044
|
|
| Accounts Receivables |
1 593 274
|
1 585 688
|
1 789 714
|
2 367 986
|
2 044 812
|
2 159 509
|
2 610 014
|
2 375 398
|
|
| Other Receivables |
411 530
|
451 946
|
326 156
|
517 851
|
482 415
|
165 886
|
404 107
|
71 646
|
|
| Inventory |
589 431
|
513 517
|
724 227
|
638 942
|
591 966
|
964 332
|
1 311 922
|
1 214 485
|
|
| Other Current Assets |
71 261
|
53 216
|
163 883
|
49 125
|
11 662
|
25 894
|
88 963
|
91 987
|
|
| Total Current Assets |
3 529 579
|
3 716 638
|
4 145 196
|
5 561 641
|
4 560 148
|
4 815 990
|
5 788 393
|
5 606 490
|
|
| PP&E Net |
3 571 483
|
3 234 381
|
2 940 768
|
2 637 295
|
2 976 570
|
2 813 956
|
2 428 563
|
2 342 859
|
|
| PP&E Gross |
3 571 483
|
3 234 381
|
2 940 768
|
2 637 295
|
2 976 570
|
2 813 956
|
2 428 563
|
2 342 859
|
|
| Accumulated Depreciation |
1 615 330
|
1 969 808
|
2 285 602
|
2 635 727
|
3 337 693
|
3 730 853
|
4 152 822
|
4 555 050
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
346 627
|
|
| Other Long-Term Assets |
120 199
|
92 510
|
93 683
|
117 117
|
107 733
|
147 941
|
165 582
|
191 878
|
|
| Total Assets |
7 221 261
N/A
|
7 043 529
-2%
|
7 179 647
+2%
|
8 316 053
+16%
|
7 644 451
-8%
|
7 777 887
+2%
|
8 382 538
+8%
|
8 487 854
+1%
|
|
| Liabilities | |||||||||
| Accounts Payable |
730 145
|
788 897
|
931 676
|
839 494
|
808 273
|
1 016 787
|
1 256 707
|
1 031 581
|
|
| Accrued Liabilities |
836 025
|
911 601
|
1 026 975
|
1 165 620
|
1 131 093
|
1 011 056
|
1 281 266
|
1 223 512
|
|
| Short-Term Debt |
954 968
|
526 728
|
256 364
|
140 899
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
35 616
|
35 913
|
38 386
|
36 849
|
437 897
|
119 567
|
92 802
|
99 052
|
|
| Other Current Liabilities |
123 582
|
126 657
|
140 395
|
132 017
|
213 374
|
242 656
|
213 670
|
188 917
|
|
| Total Current Liabilities |
2 680 336
|
2 389 796
|
2 393 796
|
2 314 879
|
2 590 637
|
2 390 066
|
2 844 445
|
2 543 062
|
|
| Long-Term Debt |
1 932 066
|
1 945 604
|
1 884 293
|
1 520 460
|
404 460
|
304 190
|
209 817
|
215 815
|
|
| Minority Interest |
341
|
283
|
184
|
266
|
492
|
817
|
1 006
|
964
|
|
| Other Liabilities |
74 895
|
109 933
|
103 854
|
139 105
|
154 714
|
143 000
|
164 523
|
165 327
|
|
| Total Liabilities |
4 687 638
N/A
|
4 445 616
-5%
|
4 382 127
-1%
|
3 974 710
-9%
|
3 150 303
-21%
|
2 838 073
-10%
|
3 219 791
+13%
|
2 925 168
-9%
|
|
| Equity | |||||||||
| Common Stock |
332 526
|
332 526
|
332 526
|
415 657
|
415 657
|
415 657
|
415 657
|
415 657
|
|
| Retained Earnings |
2 189 594
|
2 262 733
|
2 462 340
|
2 852 307
|
3 022 730
|
3 468 396
|
3 691 329
|
4 091 268
|
|
| Additional Paid In Capital |
0
|
8 849
|
8 849
|
1 061 876
|
1 064 255
|
1 064 255
|
1 064 255
|
1 064 255
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
19 997
|
19 997
|
19 997
|
19 997
|
|
| Other Equity |
11 503
|
11 503
|
11 503
|
11 503
|
11 503
|
11 503
|
11 503
|
11 503
|
|
| Total Equity |
2 533 623
N/A
|
2 597 913
+3%
|
2 797 520
+8%
|
4 341 343
+55%
|
4 494 148
+4%
|
4 939 814
+10%
|
5 162 747
+5%
|
5 562 686
+8%
|
|
| Total Liabilities & Equity |
7 221 261
N/A
|
7 043 529
-2%
|
7 179 647
+2%
|
8 316 053
+16%
|
7 644 451
-8%
|
7 777 887
+2%
|
8 382 538
+8%
|
8 487 854
+1%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
3 325
|
3 325
|
3 325
|
4 157
|
4 143
|
4 143
|
4 143
|
4 143
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
